BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29804026)

  • 1. Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results.
    Hartwig TS; Ambye L; Werge L; Weiergang MK; Nørgaard P; Sørensen S; Jørgensen FS
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():35-39. PubMed ID: 29804026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.
    Ma J; Wang Y; Wang W; Dong Y; Xu C; Zhou A; Xu Z; Wu Z; Tang X; Chen F; Yin Y; Wang W; Yan M; Zhang W; Mu F; Yang H
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):49-57. PubMed ID: 27363706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations.
    van Riel M; Brison N; Baetens M; Blaumeiser B; Boemer F; Bourlard L; Bulk S; De Leener A; Désir J; Devriendt K; Dheedene A; Duquenne A; Fieremans N; Fieuw A; Gatot JS; Grisart B; Janssens S; Khudashvili N; Lannoo L; Marichal A; Meunier C; Palmeira L; Parijs I; Pichon B; Roets E; Sammels E; Smits G; Suenaert M; Sznajer Y; Van den Bogaert K; Vancoillie L; Vandeputte L; Vantroys E; Vermeesch JR; Janssens K
    Obstet Gynecol; 2021 Jun; 137(6):1102-1108. PubMed ID: 33957658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
    Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
    Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.
    Gerundino F; Giachini C; Contini E; Benelli M; Marseglia G; Giuliani C; Marin F; Nannetti G; Lisi E; Sbernini F; Periti E; Cordisco A; Colosi E; D'ambrosio V; Mazzi M; Rossi M; Staderini L; Minuti B; Pelo E; Cicatiello R; Maruotti GM; Sglavo G; Conti A; Frusconi S; Pescucci C; Torricelli F
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):710-716. PubMed ID: 27226231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
    BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.
    Lund ICB; Petersen OB; Becher NH; Lildballe DL; Jørgensen FS; Ambye L; Skibsted L; Ernst A; Jensen AN; Fagerberg C; Brasch-Andersen C; Tabor A; Zingenberg HJ; Nørgaard P; Almind GJ; Vestergaard EM; Vogel I
    Acta Obstet Gynecol Scand; 2021 May; 100(5):884-892. PubMed ID: 33230826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
    Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.